1H-pyrrolyl-2-α-oxoacetamide | 15940-17-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1H-pyrrolyl-2-α-oxoacetamide
• 英文别名: 2-oxo-2-(1H-pyrrol-2-yl)acetamide；(2-Pyrrolyl)glyoxyloylamid；2-Oxamoyl-pyrrol；pyrrol-2-ylglyoxylamide；2-oxo-2-pyrrol-2-yl-acetamide
• CAS: 15940-17-7
• 化学式: C₆H₆N₂O₂
• mdl: MFCD19204444
• 分子量: 138.126
• InChiKey: LJDMVSIBXZGRRR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  76
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1H-pyrrolyl-2-α-oxoacetamide 在 氯化亚砜 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 2.0h， 以90%的产率得到1H-吡咯基-2-羰基腈
  参考文献：
  名称：

  A new synthesis of versatile indolyl-3-carbonylnitriles

  摘要：

  Indolyl-3-carbonylnitriles are compounds with demonstrated utility as intermediates in organic chemistry. However, their synthesis remains a challenge, requiring the use of toxic sources Of cyanide, and often proceeding in low yields. Accordingly, presented here is a new synthesis of these versatile reactants, via dehydration of easily accessible alpha-oxoacetamides in generally high yields under simple reaction conditions. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2015.07.075
• 作为产物：
  描述：

  氧代(1H-吡咯-2-基)乙酰氯 在 氯化铵 、 potassium hydroxide 作用下， 以 水 为溶剂， 生成 1H-pyrrolyl-2-α-oxoacetamide
  参考文献：
  名称：

  A new synthesis of versatile indolyl-3-carbonylnitriles

  摘要：

  Indolyl-3-carbonylnitriles are compounds with demonstrated utility as intermediates in organic chemistry. However, their synthesis remains a challenge, requiring the use of toxic sources Of cyanide, and often proceeding in low yields. Accordingly, presented here is a new synthesis of these versatile reactants, via dehydration of easily accessible alpha-oxoacetamides in generally high yields under simple reaction conditions. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2015.07.075

文献信息

• [EN] PYRROLE ANTIFUNGAL AGENTS<br/>[FR] AGENTS ANTIFONGIQUES À BASE DE PYRROLE
  申请人：F2G LTD

  公开号：WO2009130481A1

  公开（公告）日：2009-10-29

  The invention provides compounds of formula (I), and pharmaceutically and agriculturally acceptable salts thereof; wherein: R1, R2, R3, R4, R5, R6, A1, L1 and n are as defined herein. These compounds and their pharmaceutically acceptable salts are useful in prevention or treatment of a fungal disease. Compounds of formula (I), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.

  该发明提供了式(I)的化合物，以及其在药学和农业上可接受的盐；其中：R1、R2、R3、R4、R5、R6、A1、L1和n如本文所定义。这些化合物及其药学上可接受的盐在预防或治疗真菌病方面是有用的。式(I)的化合物及其农业上可接受的盐也可用作农业杀菌剂。
• Indolinone derivatives and their use in treating disease-states such as cancer
  申请人：Arnaiz Damian

  公开号：US20050090541A1

  公开（公告）日：2005-04-28

  Indolinone derivatives, such as compounds of the formula (I): wherein A, m, n, R 1 , R 2 , R 3 , R 5 and R 6 are described herein, are disclosed herein as being useful in treating mammal having disease-states alleviated by the inhibition of PDK-1 activity.

  Indolinone衍生物，例如公式（I）中的化合物：其中A，m，n，R1，R2，R3，R5和R6如本文所述，据本文披露，可用于治疗通过抑制PDK-1活性缓解疾病状态的哺乳动物。
• 1-Methoxycarbonylpyrrolizin-3-one and related compounds
  作者：Xavier L. M. Despinoy、Hamish McNab

  DOI：10.1039/b901961h

  日期：——

  Flash vacuum pyrolysis (FVP) of dimethyl E- or Z-pyrrol-2-ylbut-2-enedioate 5 at 700 °C gave 1-methoxycarbonylpyrrolizin-3-one 1. The sequence involves E- to Z-isomerisation (if necessary), elimination of methanol and cyclisation; the elimination step is rate determining. The pyrrolizinone 1 is stable at low temperatures, but at room temperature dimerises spontaneously across the 1,2-bond to give a

  E-或Z-吡咯-2-基丁-2-烯二酸酯5的快速 真空热解（FVP）在700°C下进行1-甲氧基羰基吡咯烷-3-酮 1。该序列涉及E-到Z-异构化（如有必要），消除甲醇和环化；消除步骤是确定速率。这吡咯嗪酮 1是在低温下稳定，但在室温下自发dimerises横跨1,2-键合，得到的混合物的反式-和顺式-环丁烷2和3，分别。在该过程中，1表现为羰基化烯烃。可以在> 100°C的温度下逆转二聚反应。相关的吡咯烷酮，例如酯14和22以及酰胺15对于二聚作用是稳定的。在FVP条件下，二酸12和酰胺10不会环化为吡咯烷酮，而是生成酸酐19和马来酰亚胺18， 分别; 在高炉温下2-乙炔基吡咯 从12和19获得17。
• 杂环类化合物、其制备方法及其在医药上的应用
  申请人：[en]JIANGSU HENGRUI PHARMACEUTICALS CO., LTD.;[zh]江苏恒瑞医药股份有限公司

  公开号：WO2024041613A1

  公开（公告）日：2024-02-29

  本公开涉及杂环类化合物、其制备方法及其在医药上的应用。具体而言，本公开涉及一种通式（I）所示的杂环类化合物、其制备方法及含有该类化合物的药物组合物以及其作为治疗剂的用途，特别是作为Nav抑制剂的用途和其在制备治疗和/或减轻疼痛和疼痛相关疾病的药物中的用途。其中通式（I）中各基团如说明书中所定义。
• Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 1: Design, synthesis and biological activity
  作者：Imadul Islam、Judi Bryant、Yuo-Ling Chou、Monica J. Kochanny、Wheeseong Lee、Gary B. Phillips、Hongyi Yu、Marc Adler、Marc Whitlow、Elena Ho、Dao Lentz、Mark A. Polokoff、Babu Subramanyam、James M. Wu、Daguang Zhu、Richard I. Feldman、Damian O. Arnaiz

  DOI：10.1016/j.bmcl.2007.04.071

  日期：2007.7

  HTS screening identified I with micromolar inhibitory activity against PDK1. Optimization of 1 afforded 4i (BX-517) which has single-digit nanomolar activity against PDK1 and excellent selectivity against PKA. (C) 2007 Elsevier Ltd. All rights reserved.